Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Go back to Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data| Merck & Co. (NYSE: MRK) | Delayed: 149.18 +0.88 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.30 | 52 Week High | $65.46 | |||
| Open | $147.11 | 52 Week Low | $47.97 | |||
| Day High | $149.44 | P/E | 101.48 | |||
| Day Low | $147.11 | EPS | $1.47 | |||
| Volume | 4,453,578 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.80 -0.31 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.09 | P/E | 18.06 | |||
| Day Low | $29.69 | EPS | $1.65 | |||
| Volume | 12,180,044 | |||||



